tweenvest

Latigo Biotherapeutics, Inc. (NasdaqGS: LTGO)

Health Care · Pharmaceuticals · US

$13.11

+1.39% today · -28.2% 1Y

Public summary
A free snapshot of Latigo Biotherapeutics, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Latigo Biotherapeutics, Inc. (NasdaqGS: LTGO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $869.18M and employs 66 people.

Over the last twelve months the share price has lost 28.2%, trading between 12.60 and 25.93.

Tweenvest scores Latigo Biotherapeutics, Inc. across four factors: quality 44/100, value 100/100. Its strongest factor is value.

LTGO price history

Aug 7, 2026 · 18.25Weekly closes 12.60 – 24.23Nov 13, 2026 · 13.11

Key figures

Market cap
$869.18M
Revenue (TTM)
—
P/E
-7.82
EPS
-6.86
Dividend yield
—
Beta (5Y)
—
52-week high
$25.93
52-week low
$12.60
Avg volume (3M)
—
Shares outstanding
66.30M
Employees
66
Next earnings
—

About Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.

ISIN
US5179541033
Founded
2018
Listed since
Aug 7, 2026
Exchange
Nasdaq Global Select
Currency
USD
CompanyMarket capPriceDay
Alebund Pharmaceuticals (Jiangsu) LimitedSEHK: 9637$892.36MHK$20.60-2.92%
GuangYuYuan Chinese Herbal Medicine Co., Ltd.SHSE: 600771$886.49MCN¥12.09-2.11%
Dezhan Healthcare Company LimitedSZSE: 000813$879.67MCN¥2.80-2.78%
Hunan Warrant Pharmaceutical Co.,LtdSHSE: 688799$875.28MCN¥43.72-6.14%
Guizhou Bailing Group Pharmaceutical Co., Ltd.SZSE: 002424$867.05MCN¥4.24-2.97%
Cisen Pharmaceutical Co., Ltd.SHSE: 603367$864.12MCN¥12.74-0.23%
Daewoong Pharmaceutical Co., LtdKOSE: A069620$862.36M₩99,900.00+2.36%
Sanofi Consumer Healthcare India LimitedNSEI: SANOFICONR$861.73MRs3,494.50-1.07%

Browse every Pharmaceuticals company →